TRIM8 and colorectal carcinoma: The low chemotherapy response characterising ccRCC and CRC prompted us to investigate whether miR-17-5p and miR-106b-5p might contribute to the chemotherapy resistance due to the TRIM8 protein loss, in the two paradigmatic models of these cancers.